Schmitt, D V <br/><br/>
Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia--a double blind prospective multicentre study.  [electronic resource] 

 -  Infection  Jun 2006 
 - 127-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0300-8126 
<br/><br/><label>Standard No.: </label>10.1007/s15010-006-5020-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cilastatin--adverse effects<br/>Cross Infection--drug therapy<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Imipenem--adverse effects<br/>Male<br/>Penicillanic Acid--adverse effects<br/>Piperacillin--adverse effects<br/>Pneumonia--drug therapy<br/>Prospective Studies<br/>Pseudomonas Infections--drug therapy<br/>Tazobactam<br/>Treatment Outcome